Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indofarma Tbk. (INAF) vs Harta Djaya Karya Tbk. (MEJA) Price & Performance

Indofarma Tbk.Trade
Harta Djaya Karya Tbk.Trade

Price performance (Past 24H)

Key statistics

Indofarma Tbk. vs Harta Djaya Karya Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Harta Djaya Karya Tbk. trades at Rp112 (market cap 297.32B, 17.9M 24h volume). The key difference: Indofarma Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.

INAFMEJA
Market Cap
390.51B297.32B
Volume
17.9M
Lot
179.04K
Turnover
1.99B
Average Price
111.27
Value
1.99B
Indicative Equilibrium Price
112
Indicative Equilibrium Volume
898

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INAF
View details
MEJA
View details

About Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Read more on INAF

About Harta Djaya Karya Tbk.

PT Harta Djaya Karya Tbk (the Entity) was established based on the Notarial Deed of Musa Muamarta., S.H., No. 27, dated November 22, 2012. The entity began commercial operations in 2012.

Read more on MEJA